share_log

12 Health Care Stocks Moving In Friday's Intraday Session

Benzinga ·  Dec 2, 2023 01:31

Gainers

  • NexImmune (NASDAQ:NEXI) stock moved upwards by 540.4% to $11.07 during Friday's regular session. The market value of their outstanding shares is at $11.7 million.
  • Generation Bio (NASDAQ:GBIO) shares rose 31.81% to $1.49. The company's market cap stands at $98.4 million.
  • Altimmune (NASDAQ:ALT) shares rose 28.48% to $4.06. The market value of their outstanding shares is at $218.1 million.
  • Cyclerion Therapeutics (NASDAQ:CYCN) stock increased by 22.01% to $2.66. The company's market cap stands at $6.5 million.
  • Processa Pharma (NASDAQ:PCSA) shares rose 21.87% to $0.78. The company's market cap stands at $19.2 million.
  • Genelux (NASDAQ:GNLX) shares moved upwards by 21.0% to $14.4. The market value of their outstanding shares is at $384.7 million.

Losers

  • Ampio Pharmaceuticals (AMEX:AMPE) shares fell 42.7% to $3.3 during Friday's regular session. The company's market cap stands at $2.7 million.
  • Intelligent Bio Solutions (NASDAQ:INBS) shares declined by 28.46% to $0.3. The company's market cap stands at $2.6 million.
  • LumiraDx (NASDAQ:LMDX) stock declined by 23.54% to $0.13. The market value of their outstanding shares is at $42.0 million.
  • Soligenix (NASDAQ:SNGX) stock declined by 20.41% to $0.78. The market value of their outstanding shares is at $8.0 million.
  • Cartesian Therapeutics (NASDAQ:RNAC) shares declined by 20.0% to $1.08. The market value of their outstanding shares is at $174.8 million.
  • Ensysce Biosciences (NASDAQ:ENSC) shares decreased by 19.79% to $0.91. The company's market cap stands at $2.8 million. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment